Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,722 | 205 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $755.25 | 50 | $0 (2024) |
| Lilly USA, LLC | $628.77 | 47 | $0 (2024) |
| ABBVIE INC. | $353.63 | 14 | $0 (2024) |
| PFIZER INC. | $309.76 | 22 | $0 (2024) |
| ENCORE MEDICAL, LP | $238.77 | 4 | $0 (2021) |
| Merck Sharp & Dohme LLC | $137.39 | 8 | $0 (2024) |
| Biohaven Pharmaceutical Holding Company Ltd. | $129.30 | 6 | $0 (2022) |
| DJO, LLC | $118.19 | 1 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $115.62 | 6 | $0 (2024) |
| Abbott Laboratories | $111.72 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $890.13 | 51 | Novo Nordisk Inc ($204.38) |
| 2023 | $1,024 | 65 | Novo Nordisk Inc ($245.52) |
| 2022 | $1,010 | 62 | Novo Nordisk Inc ($211.65) |
| 2021 | $425.89 | 15 | ENCORE MEDICAL, LP ($238.77) |
| 2020 | $94.29 | 4 | DePuy Synthes Sales Inc. ($43.40) |
| 2019 | $166.65 | 4 | DJO, LLC ($118.19) |
| 2018 | $63.02 | 1 | Bioventus LLC ($63.02) |
| 2017 | $48.08 | 3 | SANOFI-AVENTIS U.S. LLC ($18.23) |
All Payment Transactions
205 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $21.80 | General |
| 12/03/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: Inflammation | ||||||
| 11/26/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.15 | General |
| Category: Diabetes | ||||||
| 11/22/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $12.36 | General |
| Category: Obesity | ||||||
| 11/19/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: Diabetes | ||||||
| 11/15/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.97 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: Endocrinology | ||||||
| 11/05/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $23.43 | General |
| Category: Diabetes Care | ||||||
| 11/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: DIABETES | ||||||
| 11/01/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: Oncology | ||||||
| 10/22/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: Diabetes | ||||||
| 10/15/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: PAIN | ||||||
| 09/20/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: NEUROSCIENCE | ||||||
| 09/19/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $12.54 | General |
| Category: Diabetes | ||||||
| 09/17/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: Diabetes | ||||||
| 09/13/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $22.65 | General |
| Category: Endocrinology | ||||||
| 08/30/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.61 | General |
| Category: Obesity | ||||||
| 08/27/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: Diabetes | ||||||
| 08/23/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: VACCINES | ||||||
| 08/20/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $24.09 | General |
| Category: NEUROSCIENCE | ||||||
| 08/13/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $21.62 | General |
| Category: Diabetes | ||||||
| 08/06/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $19.91 | General |
| Category: Diabetes Care | ||||||
| 08/06/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: PAIN | ||||||
| 07/30/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $27.34 | General |
| Category: NEUROSCIENCE | ||||||
| 07/26/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $9.57 | General |
| Category: Obesity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 852 | 1,033 | $150,261 | $74,127 |
| 2022 | 11 | 956 | 1,103 | $148,395 | $75,560 |
| 2021 | 13 | 848 | 973 | $120,743 | $59,555 |
| 2020 | 6 | 162 | 223 | $44,382 | $11,629 |
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 198 | 309 | $59,637 | $24,587 | 41.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 177 | 177 | $36,816 | $22,182 | 60.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 148 | 179 | $23,270 | $9,118 | 39.2% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 23 | 23 | $10,925 | $6,477 | 59.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 48 | 48 | $5,088 | $3,442 | 67.7% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 15 | 15 | $4,500 | $2,417 | 53.7% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 13 | 13 | $4,017 | $2,091 | 52.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 143 | 182 | $2,184 | $1,529 | 70.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 51 | 51 | $2,295 | $1,497 | 65.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 23 | 23 | $1,035 | $675.28 | 65.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 13 | 13 | $494.00 | $111.40 | 22.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 191 | 248 | $47,864 | $21,092 | 44.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 157 | 157 | $32,656 | $20,078 | 61.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 198 | 229 | $29,770 | $13,344 | 44.8% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 40 | 40 | $12,360 | $6,607 | 53.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 75 | 75 | $7,950 | $5,124 | 64.5% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 11 | 11 | $5,225 | $3,059 | 58.5% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 14 | 14 | $4,200 | $2,304 | 54.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 81 | 82 | $3,690 | $2,295 | 62.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 158 | 216 | $2,592 | $640.14 | 24.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 20 | 20 | $900.00 | $562.68 | 62.5% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 11 | 11 | $1,188 | $454.01 | 38.2% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2021 | 85 | 85 | $26,265 | $14,100 | 53.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 120 | 156 | $30,108 | $13,621 | 45.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 157 | 173 | $22,490 | $10,365 | 46.1% |
About Dr. Brian Fuller, MD
Dr. Brian Fuller, MD is a Sports Medicine healthcare provider based in Cincinnati, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/29/2011. The National Provider Identifier (NPI) number assigned to this provider is 1780973982.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brian Fuller, MD has received a total of $3,722 in payments from pharmaceutical and medical device companies, with $890.13 received in 2024. These payments were reported across 205 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($3,722).
As a Medicare-enrolled provider, Fuller has provided services to 2,818 Medicare beneficiaries, totaling 3,332 services with total Medicare billing of $220,871. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Practice Information
- Specialty Sports Medicine
- Other Specialties Family Medicine
- Location Cincinnati, OH
- Active Since 03/29/2011
- Last Updated 03/04/2021
- Taxonomy Code 207QS0010X
- Entity Type Individual
- NPI Number 1780973982
Products in Payments
- MOUNJARO (Drug) $389.40
- Ozempic (Drug) $374.85
- DJO SURGICAL (Device) $238.77
- Rybelsus (Drug) $224.19
- UBRELVY (Drug) $213.91
- NURTEC ODT (Drug) $196.46
- PREVNAR 20 (Biological) $192.51
- QULIPTA (Drug) $139.72
- TRULICITY (Drug) $139.68
- FREESTYLE LIBRE 3 (Device) $111.72
- Dexcom G6 Transmitter (Medical Supply) $109.71
- Wegovy (Drug) $101.91
- JARDIANCE (Drug) $97.82
- Cologuard Collection Kit (Device) $80.99
- BELSOMRA (Drug) $77.88
- Durolane (Device) $63.02
- EMGALITY (Drug) $62.10
- ADUHELM (Biological) $61.38
- INPEN SMART INSULIN DELIVERY SYSTEM (Device) $54.47
- ELIQUIS (Drug) $50.09
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Sports Medicine Doctors in Cincinnati
Mr. Vincent Sammarco, M.d, M.D
Sports Medicine — Payments: $397,265
Dr. Melissa Summers, Md, MD
Sports Medicine — Payments: $86,575
Dr. Brian Grawe, Md, MD
Sports Medicine — Payments: $45,612
Michelle Andrews, Md, MD
Sports Medicine — Payments: $35,431
Frank Noyes, Md, MD
Sports Medicine — Payments: $29,986
Dr. Ian Rice, Md, MD
Sports Medicine — Payments: $26,283